VJX-25039-36518
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 481 / MI
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-14
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-03-04
- 2021-04-22
-
2021-07-23
Survey response — 6 months, dose 2MedDRA: Eyelid infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Eyelid infectiomMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-23
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-23 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Eyelid infectiom
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eyelid infection | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release